Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary W Redman

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|October 5, 2015
The Master Protocol ConceptMary W Redman, Carmen J Allegra
JAMA Oncology|February 10, 2022
Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer-ReplyScott Gettinger, Mary W Redman, Roy S Herbst
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2023
Moving Toward Rationale Phase 3 Designs for Advanced NSCLCMarion Ferreira, Mary W Redman, Karen L Reckamp
Statistics in Medicine|September 11, 2019
Quantifying treatment effects using the personalized chance of longer survivalYing-Qi Zhao, Mary W Redman, Michael L LeBlanc
Journal of the National Cancer Institute. Monographs|October 24, 2007
Do general dimensions of quality of life add clinical value to symptom data?Carol M Moinpour, Gary W Donaldson, Mary W Redman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer"Primo N Lara, David R Gandara, Mary W Redman
Journal of the American Statistical Association|June 8, 2010
Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity AnalysisBryan E Shepherd, Mary W Redman, Donna P Ankerst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Modeling the relationship between progression-free survival and overall survival: the phase II/III trialMary W Redman, Bryan H Goldman, Michael LeBlanc, et al.
Chinese Clinical Oncology|September 27, 2015
Lung-MAP--framework, overview, and design principlesRenata Ferrarotto, Mary W Redman, David R Gandara, et al.
Cancer|September 11, 2023
Racial disparities in the screening mammography continuum within a heterogeneous health care systemAnisha P Ganguly, Kelsey K Baker, Mary W Redman, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|October 5, 2015
The Master Protocol ConceptMary W Redman, Carmen J Allegra
JAMA Oncology|February 10, 2022
Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer-ReplyScott Gettinger, Mary W Redman, Roy S Herbst
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2023
Moving Toward Rationale Phase 3 Designs for Advanced NSCLCMarion Ferreira, Mary W Redman, Karen L Reckamp
Statistics in Medicine|September 11, 2019
Quantifying treatment effects using the personalized chance of longer survivalYing-Qi Zhao, Mary W Redman, Michael L LeBlanc
Journal of the National Cancer Institute. Monographs|October 24, 2007
Do general dimensions of quality of life add clinical value to symptom data?Carol M Moinpour, Gary W Donaldson, Mary W Redman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2015
Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer"Primo N Lara, David R Gandara, Mary W Redman
Journal of the American Statistical Association|June 8, 2010
Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity AnalysisBryan E Shepherd, Mary W Redman, Donna P Ankerst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Modeling the relationship between progression-free survival and overall survival: the phase II/III trialMary W Redman, Bryan H Goldman, Michael LeBlanc, et al.
Chinese Clinical Oncology|September 27, 2015
Lung-MAP--framework, overview, and design principlesRenata Ferrarotto, Mary W Redman, David R Gandara, et al.
Cancer|September 11, 2023
Racial disparities in the screening mammography continuum within a heterogeneous health care systemAnisha P Ganguly, Kelsey K Baker, Mary W Redman, et al.
Pageof 9